succinylcholine
succinylcholine: sourced relationships with 1 company · 1 FDA decision.
succinylcholine evidence translation
What we can confirm
1 FDA record
What it means
What to watch
Prepared research question
How could succinylcholine → NEXS affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
Dated Pipeline Records (2)
| Company | Dated record stage |
|---|---|
| NEXUS BIOPHARMA INC (NEXS) Reported 2020-10-27 · Current development: unknownSource | Approved |
| NEXUS BIOPHARMA INC (NEXS) Reported 2020-10-27 · Current development: unknownSource | Approved |
FDA Decisions1 records
Frequently asked questions
Which companies have sourced relationships with succinylcholine?
succinylcholine has dated SEC/FDA relationship records for NEXUS BIOPHARMA INC.
What is succinylcholine's latest FDA decision?
The most recent tracked FDA decision for succinylcholine is Approval for 1 INDICATIONS AND USAGE Succinylcholine chloride injection is indicated in adults and pediatric patients: as an adjunct to general anesthesia to facilitate tracheal intubation to provide skeletal muscle relaxation during surgery or mechanical ventilation. Succinylcholine chloride is a depolarizing neuromuscular blocker indicated in adults and pediatric patients: as an adjunct to general anesthesia ( 1 ) to facilitate tracheal intubation ( 1 ) to provide skeletal muscle relaxation during surgery , dated October 27, 2020.